High Quality Antibodies

News

13 11, 2014

April 2014

2018-08-01T14:27:23+00:00November 13th, 2014|News|

CRT exclusive agreement: Vertebrate Antibodies Ltd reached an agreement with Cancer Research Technology (CRT) to exclusively license a number of their monoclonal antibodies for Research Only.  The antibodies are specific towards the following human targets; BCLAF1, CCT2, CYP1A2, CYP1A, CYP2A6, CYP2E1, CYP2R1, CYP4F11, CYP4A11, CYP4V2, CYP4Z1, CYP3A4, CYP3A5, [...]

13 11, 2014

January 2014

2018-08-01T14:27:44+00:00November 13th, 2014|News|

SMART-SCOTLAND feasibility study award “Discovery of colorectal cancer biomarkers and validation of antibodies towards them for use as diagnostic or therapeutic agents”.  Over the duration of 18 months and in collaboration with Professor Graeme Murray at Aberdeen University, the projects aims to deliver a portfolio of novel tumour [...]

13 11, 2014

January 2012

2018-08-01T14:28:07+00:00November 13th, 2014|News|

Knowledge Transfer and Exchange Award in collaboration with Dr Jun Zou at the Scottish Fish Immunology Research Centre (SFIRC). The award aimed at developing assays to monitor vaccine performance in salmonids. Outcome:  monoclonal antibodies are developed to key cytokines i.e. INFg. Quantitative and qualitative assays are being optimised [...]

13 11, 2014

July 2012

2018-08-01T14:28:50+00:00November 13th, 2014|News|

Kick Start award in collaboration with Professor Graeme Murray, University of Aberdeen, with focus on the discovery of colorectal cancer biomarkers and the validation of antibodies towards them for use as prognostic agents. Outcome: The project targeted retinoic acid metabolising enzymes. Retinoic acid is a metabolite of vitamin [...]

Do NOT follow this link or you will be banned from the site!